UCPH School of Pharmaceutical Sciences

Vision China highlights crucial role of science and technology

Retrieved on: 
Monday, November 6, 2023

A wide range of scientific and technological exchanges and cooperation both in China and across the world were highlighted at the Vision China event on Monday in the sci-tech powerhouse of Wuhan in Central China's Hubei province.

Key Points: 
  • A wide range of scientific and technological exchanges and cooperation both in China and across the world were highlighted at the Vision China event on Monday in the sci-tech powerhouse of Wuhan in Central China's Hubei province.
  • Under the theme "Leading to the Future with Technological Innovation," Vision China sought to highlight the crucial role of science and technology in contributing to the country's next stage of development.
  • At the event, hosted jointly by China Daily and Wuhan Municipal People's Government, speakers from various sectors outlined the key trends and functions of fields including manufacturing, artificial intelligence and agricultural technology.
  • "China's achievements in science and technology have not only been a result of global cooperation, but have also made valuable contributions to the international community," Liu said.

2023 Tsinghua Amgen Scholars Program Kicks Off

Retrieved on: 
Thursday, July 27, 2023

SHANGHAI, July 27, 2023 /PRNewswire/ -- Recently, 2023 Amgen Scholar Program (ASP) was opened in China, partnering with Tsinghua University, one of China's top academic institutions and influential universities. 24 undergraduates were selected as Amgen Scholars from across the globe to participate in this program with one-third of the chosen scholars coming from international universities this year. They will have the opportunity to engage in cutting-edge scientific research with world class scientists in state-of-the-art research laboratories. It is the largest in-person summer camp ASP held since the COVID-19 global pandemic.

Key Points: 
  • SHANGHAI, July 27, 2023 /PRNewswire/ -- Recently, 2023 Amgen Scholar Program (ASP) was opened in China, partnering with Tsinghua University, one of China's top academic institutions and influential universities.
  • 24 undergraduates were selected as Amgen Scholars from across the globe to participate in this program with one-third of the chosen scholars coming from international universities this year.
  • Amgen Scholars at the Tsinghua University consists of eight weeks of intensive research program in a wide range of fields in biomedical sciences.
  • says Ligong Chen, Associate Dean, School of Pharmaceutical Sciences, Tsinghua University Program Director, Tsinghua Amgen Scholars Program.

Call for Application for 2023 Tsinghua Amgen Scholars Program

Retrieved on: 
Tuesday, January 3, 2023

BEIJING, Jan. 3, 2023 /PRNewswire/ -- The Amgen Scholars Program (ASP) is an international program funded by the Amgen Foundation with the direction of Harvard University, aiming to increase research opportunities for students committed to pursuing careers in the field of biomedical science.

Key Points: 
  • BEIJING, Jan. 3, 2023 /PRNewswire/ -- The Amgen Scholars Program (ASP) is an international program funded by the Amgen Foundation with the direction of Harvard University, aiming to increase research opportunities for students committed to pursuing careers in the field of biomedical science.
  • So far, 24 premier educational and research institutions across the U.S., Europe, Asia, Australia and Canada have hosted the summer program, including 4 institutions in Asia, which are National University of Singapore, University of Tokyo, Kyoto University and Tsinghua University.
  • Each scholar will be assigned to a faculty member as his/her mentor during the research program.
  • Tsinghua University will continue to provide an excellent program upon the success of previous programs with the Amgen Foundation.

Call for Application for 2023 Tsinghua Amgen Scholars Program

Retrieved on: 
Tuesday, January 3, 2023

BEIJING, Jan. 3, 2023 /PRNewswire/ -- The Amgen Scholars Program (ASP) is an international program funded by the Amgen Foundation with the direction of Harvard University, aiming to increase research opportunities for students committed to pursuing careers in the field of biomedical science.

Key Points: 
  • BEIJING, Jan. 3, 2023 /PRNewswire/ -- The Amgen Scholars Program (ASP) is an international program funded by the Amgen Foundation with the direction of Harvard University, aiming to increase research opportunities for students committed to pursuing careers in the field of biomedical science.
  • So far, 24 premier educational and research institutions across the U.S., Europe, Asia, Australia and Canada have hosted the summer program, including 4 institutions in Asia, which are National University of Singapore, University of Tokyo, Kyoto University and Tsinghua University.
  • Each scholar will be assigned to a faculty member as his/her mentor during the research program.
  • Tsinghua University will continue to provide an excellent program upon the success of previous programs with the Amgen Foundation.

Vaccines alone aren't enough to combat AMR, claims new WHO report

Retrieved on: 
Friday, July 22, 2022

LONDON, July 22, 2022 /PRNewswire/ -- A recent report published by the World Health Organization (WHO) identified vaccines as "highly effective tools in combating AMR". Despite their efficacy, the financial risks and approval processes for vaccine development continue to restrict their use as an immediate solution to the AMR crisis. It was concluded that short-term solutions to prevent resistance must focus on interventions other than vaccines, highlighting the importance of research and investment in other methods of control, including effective infection prevention.

Key Points: 
  • LONDON, July 22, 2022 /PRNewswire/ --A recent report published by the World Health Organization (WHO) identified vaccines as "highly effective tools in combating AMR".
  • Despite their efficacy, the financial risks and approval processes for vaccine development continue to restrict their use as an immediate solution to the AMR crisis.
  • The GHC welcomes this report and advocates the use of hygiene alongside vaccinations in controlling the spread of infections and reducing the impact of AMR.
  • As witnessed throughout the COVID-19 pandemic, hygiene plays an invaluable role in helping to prevent the spread of infections.

Vaccines alone aren't enough to combat AMR, claims new WHO report

Retrieved on: 
Friday, July 22, 2022

LONDON, July 22, 2022 /PRNewswire/ -- A recent report published by the World Health Organization (WHO) identified vaccines as "highly effective tools in combating AMR". Despite their efficacy, the financial risks and approval processes for vaccine development continue to restrict their use as an immediate solution to the AMR crisis. It was concluded that short-term solutions to prevent resistance must focus on interventions other than vaccines, highlighting the importance of research and investment in other methods of control, including effective infection prevention.

Key Points: 
  • LONDON, July 22, 2022 /PRNewswire/ --A recent report published by the World Health Organization (WHO) identified vaccines as "highly effective tools in combating AMR".
  • Despite their efficacy, the financial risks and approval processes for vaccine development continue to restrict their use as an immediate solution to the AMR crisis.
  • The GHC welcomes this report and advocates the use of hygiene alongside vaccinations in controlling the spread of infections and reducing the impact of AMR.
  • As witnessed throughout the COVID-19 pandemic, hygiene plays an invaluable role in helping to prevent the spread of infections.

Experts warn that post-COVID hygiene lethargy could put millions at risk of fatal infections due to antimicrobial resistance

Retrieved on: 
Friday, November 19, 2021

As we continue to address the impact of COVID-19, there is an even greater public health threat which must be tackled, AMR.

Key Points: 
  • As we continue to address the impact of COVID-19, there is an even greater public health threat which must be tackled, AMR.
  • Last month the WHO launched its report on the state of the world's hand hygiene, outlining the importance of hand hygiene in preventing infections and reducing the burden ofAMR through extending the life of antimicrobials (e.g.
  • Behaviours such as handwashing have the potential to reduce disease transmission, as experienced with COVID-19 and should be encouraged post-pandemic".
  • Adopting everyday hygiene practices can reduce the risk of common infections by up to 50% and offers a framework for reducing antibiotic prescribing, minimising opportunities for antibiotic resistant bacteria to form.

Experts warn that post-COVID hygiene lethargy could put millions at risk of fatal infections due to antimicrobial resistance

Retrieved on: 
Friday, November 19, 2021

LONDON, Nov. 19, 2021 /PRNewswire/ -- With over 5 million deaths worldwide, COVID-19 has imposed a significant burden on societies and healthcare systems around the world. As we continue to address the impact of COVID-19, there is an even greater public health threat which must be tackled, AMR. The importance of hygiene's role in breaking the chain of infection has been demonstrated during the COVID-19 pandemic, however GHC experts fear that we are witnessing hygiene lethargy as we transition into a post-COVID world, exacerbating the threat of AMR.

Key Points: 
  • The Global Hygiene Council (GHC) are calling on us to practice good hygiene, such as handwashing, to prevent the spread of infectious diseases and reduce the impact of antimicrobial resistance (AMR).
  • LONDON, Nov. 19, 2021 /PRNewswire/ -- With over 5 million deaths worldwide, COVID-19 has imposed a significant burden on societies and healthcare systems around the world.
  • As we continue to address the impact of COVID-19, there is an even greater public health threat which must be tackled, AMR.
  • Behaviours such as handwashing have the potential to reduce disease transmission, as experienced with COVID-19 and should be encouraged post-pandemic".

New progress of studies on Lianhua Qingwen's mechanism to fight against SARS-CoV-2

Retrieved on: 
Thursday, November 4, 2021

In addition, with the increasing popularity of the drug, scientists have carried out a series of basic and clinical studies, proving its effectiveness with data evidence.

Key Points: 
  • In addition, with the increasing popularity of the drug, scientists have carried out a series of basic and clinical studies, proving its effectiveness with data evidence.
  • Based on HRMS and intelligent untargeted data mining technology, this study comprehensively analyzes the components of Lianhua Qingwen Capsules in plasma and urine after repeated administration.
  • In this study, TCMSP and TCMID databases as well as related literature are used to screen out the active ingredients and targets of Lianhua Qingwen.
  • During the pandemic, Lianhua Qingwen has been widely used in the mobile cabin hospitals in Wuhan, China, including Huoshenshan Hospital and Leishenshan Hospital.

New progress of studies on Lianhua Qingwen's mechanism to fight against SARS-CoV-2

Retrieved on: 
Thursday, November 4, 2021

In addition, with the increasing popularity of the drug, scientists have carried out a series of basic and clinical studies, proving its effectiveness with data evidence.

Key Points: 
  • In addition, with the increasing popularity of the drug, scientists have carried out a series of basic and clinical studies, proving its effectiveness with data evidence.
  • Based on HRMS and intelligent untargeted data mining technology, this study comprehensively analyzes the components of Lianhua Qingwen Capsules in plasma and urine after repeated administration.
  • In this study, TCMSP and TCMID databases as well as related literature are used to screen out the active ingredients and targets of Lianhua Qingwen.
  • During the pandemic, Lianhua Qingwen has been widely used in the mobile cabin hospitals in Wuhan, China, including Huoshenshan Hospital and Leishenshan Hospital.